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INTRODUCTION
Knowledge of the influences of anesthetics on cere-
bral blood flow (CBF) and metabolism is an important
issue in human medicine, especially for patients with
elevated intracranial pressure or who are scheduled for
neurosurgery. The main goal of the anesthesiologist in
these cases is to prevent the occurrence of secondary
brain injuries and cerebral ischemia (Audibert et al.,
2005; Van Aken and Van Hemelrijck, 1991). In addi-
tion, it is important to be aware of the effect of seda-
tives or anesthetics on the regional or global brain per-
fusion when functional brain imaging modalities to
assess (regional) cerebral blood flow (rCBF) are ap-
plied in veterinary patients (Peremans et al., 2001). Fi-
nally, altered cerebral circulation induced by anesthe-
sia can influence the disposability of the radioligands
when neurotransmitter systems are evaluated using
specific radioligands, as already reported in cats (Has-
soun et al., 2003).
Sedatives and anesthetics affect not only the cere-
bral metabolism, but also the respiratory and cardio-
vascular dynamics. All these parameters have clear
influences on the cerebral blood flow. Consequently,
the administration of anesthetics can be accompanied
by several, sometimes opposing influences on the cere-
bral blood flow, whereby the final effect is difficult to
predict. Most anesthetics cause an inhibition of the
neuronal activity, resulting in decreased cerebral me-
tabolism, which in turn causes the cerebral vessels to
constrict. Simultaneously, these anesthetics can induce
hypoventilation, accompanied by hypercapnia, or hy-
potension. Both hypoventilation and hypotension in-
duce vasodilation or at least blunt the vasoconstriction
resulting from the formerly mentioned decreased me-
tabolism. Another concern is the change in cerebral
blood flow in a region dependant manner induced by
some anesthetic agents (Schlunzen et al., 2006). 
Since anesthesia is mandatory in veterinary medi-
cine for procedures where cerebral blood flow is mea -
sured, the effects of commonly used sedatives and
anesthetics on the cerebral blood flow are reviewed in
the present paper.
Influence of α2-agonists
Alpha2-agonists induce a reliable dose dependent
sedation, analgesia and muscle relaxation, and are
widely used in veterinary medicine. The α2-receptors
are located both in neuronal and also in non-neuronal
tissues, including in the vascular endothelium and
platelets throughout the body; norepinephrine (NE) is
the most important endogenous ligand for these re-
ceptors (Kanawati et al., 1986; Tsukahara et al., 1986).
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ABSTRACT
Sedatives and anesthetics can influence cerebral metabolism and respiratory and cardiovascular dynamics,
which results in changes in cerebral perfusion. This is of major importance when functional brain imaging
techniques are used to measure cerebral blood flow or to evaluate neurotransmitter systems, and also during
neurosurgery. In the present review, the influences on brain perfusion of different sedatives including opioids
and anesthetics commonly used in veterinary medicine are summarized.
SAMENVATTING
Sedativa en anesthetica kunnen de ventilatie, het cardiovasculaire systeem en het metabolisme van de hersenen
beïnvloeden. Dit kan resulteren in veranderingen in de hersendoorbloeding, hetgeen van belang kan zijn wanneer
functionele beeldvormingstechnieken gebruikt worden om de hersenperfusie te meten, om neurotransmittersystemen
te beoordelen of ook tijdens neurochirurgie. In dit tweede deel over hersenperfusie wordt de invloed van
diergeneeskundig regelmatig gebruikte sedativa, opiaten en anesthetica op de hersenperfusie besproken.
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All norepinephrine receptors can be postsynaptic
heteroreceptors, but only the α2-receptors can act as
presynaptic autoreceptors, producing a negative feed-
back regulatory signal when stimulated. The most im-
portant effect of α2-receptor stimulation in the central
nervous system is an inhibition of the release of NE, re-
sulting in decreased centrally mediated sympathetic ac-
tivity and sedation (Aghajanian and Vandermaelen,
1982; Bhana et al., 2000; Kamibayashi and Maze,
2000; Lipscombe et al., 1989; Prielipp et al., 2002;
Stahl, 2008).
Alpha2-agonists cause an initial peripheral vaso-
constriction, which leads to increased blood pressure,
which in turn causes a reflex  bradycardia. The cen-
trally induced decrease of the sympathetic nervous
tone also leads to a decreased heart rate and blood
pressure. Since hypotension was not reported in clini-
cal studies in dogs, this species might be more sensi-
tive for the vasoconstrictor effects of α2-agonists com-
pared to humans (Khan et al., 1999; Lemke, 2007;
Murrell and Hellebrekers, 2005; Pypendop and Ver-
stegen, 1998).
Overall, α2-agonists have cerebral protecting pro -
perties as they decrease intracranial pressure (ICP) by
reducing cerebral blood volume. Since most of the
blood volume is situated in the venous compartment
and α2-agonists are potent vasopressors on the venous
side of the cerebral pial circulation, a decrease in ICP
can be expected. However, a possible autoregulatory
response can counteract the previously mentioned
intrinsic effect of α2-agonists on the cerebral perfusion
(Iida et al., 1999; Ter Minassian et al., 1997). Systemic
administration of α2-agonists not only decreases global
CBF but also limits hypercapnia- and hypoxia-induced
cerebral vasodilation (Fale et al., 1994; McPherson et
al., 1994; Zornow et al., 1990). 
Xylazine
Administration of xylazine in isoflurane anes-
thetized rats was reported to induce a region-dependent
reduction in CBF (largest reduction in the hypothala-
mus and septum, smallest reduction in the caudate
putamen) (Lei et al., 2001). This reduction in CBF
could partly be explained by the well known effects of
xylazine on the cardiac output, the respiratory system
and the cerebral perfusion pressure, but also by direct
effects on central and peripheral α2-receptors. Whether
the coupling between CBF and the cerebral metabolic
rate of oxygen consumption (CMRO2), which is a re-
flection of the oxygen requirements for the brain, re-
mains intact under anesthesia including xylazine was
left unclear. In a model of intracranial hypertension in
dogs, a significant dose-dependent decrease in ICP af-
ter administration of xylazine was also demonstrated
(Mccormick et al., 1993).
Medetomidine and dexmedetomidine
Although the racemic mixture of medetomidine ad-
ministered in isoflurane anesthetized dogs was re-
ported to be accompanied by significant increases in
systolic and diastolic pressure, surprisingly this mixture
did not significantly change the intracranial pressure
(Keegan et al., 1995).
In contrast, dexmedetomidine, which is the S-enan-
tiomer of medetomidine, was reported to induce a sig-
nificant decrease in CBF in isoflurane or halothane
anesthetized dogs. However, this decrease in CBF
could not be associated with a significant increase in
mean arterial pressure or a change in the cerebral meta-
bolic rate of oxygen (CMRO2), most likely because
dexmedetomidine was administered as a continuous in-
fusion over 15 minutes. Therefore, the observed CBF
decrease was presumably induced by the occurrence of
an α2-receptor-mediated vasoconstriction. In addition,
the possibility of the inhibition of specific brain regions
with dense concentrations of α2-receptors has also been
mentioned (Karlsson et al., 1990; Prielipp et al., 2002;
Zornow et al., 1990). The reduction of the volatile
anesthetic induced vasodilation by dexmedetomidine
was further confirmed in a closed cranial window CBF
study in dogs, where the reduction in diameter of pial
vessels after the intravenous administration of
dexmedetomidine was more striking in arterioles than
in venules and was not dose dependent (Ohata et al.,
1999). However, cerebral pial venules tended to exhibit
more prominent constriction compared to arterioles
when dexmedetomidine was administered topically in
man, while an opposite effect was noticed in the spinal
vessels. As not only the pial vessels but also the intra-
parenchymal arterioles play a role in the regulation of
the CBF, conclusions regarding the CBF cannot be
made by observing only the pial vessel diameters (Iida
et al., 1999).
Apparently, the vasoconstrictive effects of α2-ago-
nists are of greater importance for the cerebral vascu-
lature than the autoregulatory mechanisms, resulting in
decreased CBF and ICP. 
Influence of benzodiazepines
As benzodiazepines can cause dysphoria and exci-
tation after intravenous administration in small animals,
these drugs are seldom used as a sole sedative in these
species (Court and Greenblatt, 1992; Covey-Crump
and Murison, 2008; Ilkiw et al., 1996; Stegmann and
Bester, 2001). However, these drugs are routinely used
in combination with other sedatives, injectable anes-
thetics and ketamine because of their good muscle re-
laxant effect and limited effects on cardiovascular and
pulmonary functions. Benzodiazepines are also fre-
quently used as anticonvulsants (Itamoto et al., 2000;
Lemke, 2007). 
Benzodiazepines produce most of their pharmaco-
logical effects by modulating the γ-aminobutyric acid
(GABA)-mediated neurotransmission. GABA is a pri-
mary inhibitory neurotransmitter in the mammalian
nervous system since cell membranes of most central
nervous system neurons express GABA receptors
(Tanelian et al., 1993). When benzodiazepines interact
with these specific receptors, the GABA-mediated
chloride ion conductance is potentiated so the net re-
sult is enhancement of GABA-mediated inhibitory
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synaptic events. As inhibitory changes in neuron ac-
tivity of a certain brain region result in decreased re-
gional cerebral blood flow (rCBF) and because of the
widespread distribution of GABAergic neurons and
their corresponding receptors, changes in rCBF can be
seen after the administration of benzodiazepines
(Matthew et al., 1995). The administration of benzo-
diazepines was indeed associated with decreases in
rCBF and glucose utilization in an experimental rat
study (Kelly et al., 1986). Moreover, different benzo-
diazepines, including triazolam, midazolam and lo-
razepam, significantly reduced both CBF and the cere-
bral metabolic rate in humans, dogs and piglets
(Ahmad et al., 2000; Forster et al., 1982; Roald et al.,
1986; Yeh et al., 1988). In another human study, this ef-
fect was proven to be mediated, at some level, through
the benzodiazepine site located on the GABA receptor,
since flumazenil, the classic benzodiazepine antagonist,
was able to reverse this effect. The largest reductions
in rCBF were seen in the thalamus, a region where, sur-
prisingly, the density of benzodiazepine binding sites
is the lowest. This finding suggests that benzodia -
zepines produce changes in the activity of neurons in
regions removed from but connected to areas of high
binding site density (Matthew et al., 1995).  
As benzodiazepines produce only minimal effects
on cardiovascular and pulmonary functions in dogs, a
change in CBF is not induced by changes in arterial
partial pressure of oxygen or carbon dioxide or by
fluctuations in blood pressure (Haskins et al., 1986;
Hellyer et al., 1991; Jones et al., 1979).
Influence of opioids
Opioids are frequently used in man and animals in
combination with sedatives or anesthetics for their po-
tent analgesic effects. They exert their effect on cere-
bral hemodynamics mainly through the cardiorespira-
tory changes that they induce. However, most opioids
have minimal effects in animals on cardiac output,
cardiac rhythm and arterial blood pressure when clin-
ically relevant analgesic doses are administered (La-
mont and Mathews, 2007). The responsiveness of the
brain-stem respiratory centers to carbon dioxide, on the
other hand, is of importance. Indeed, opioids can de-
crease this responsiveness, especially during general
anesthesia, causing a marked hypercapnia, which re-
sults in an increase in CBF (Akca, 2006; Cullen et al.,
1999; Lamont and Mathews, 2007).
Another important issue relating to the use of opi-
oids in small animals is the occurrence of hypotension,
which can influence cerebral hemodynamics (Bedell et
al., 1998; Lamont and Mathews, 2007; Matsumiya
and Dohi, 1983; Werner et al., 1992). However, several
human studies have confirmed that ICP does not in-
crease after the administration of opioids when CO2
and blood pressure are kept constant (Albanese et al.,
1997; Bazin, 1997; Bourgoin et al., 2005; Paris et al.,
1998).  Studies in dogs showed a decrease in CBF and
CMRO2, but a stable or even decreased ICP when
morphine, sufentanil or remifentanil were adminis-
tered during halothane or isoflurane anesthesia (Hoff-
man et al., 1993; Matsumiya and Dohi, 1983; Werner
et al., 1992).
In conclusion, CBF remains stable or may possibly
decrease after the administration of opioids, on the
condition that blood pressure and arterial carbon dio -
xide tension are kept constant.
Influence of injectable anesthetics
Most injectable anesthetic drugs used in veterinary
medicine (i.e. barbiturates, propofol, etomidate and
alfaxalone) alter the transmission mediated by the in-
hibitory neurotransmitter GABA (GABAA more speci -
fically). Prediction of activity and individual drug phar-
macology is complicated by the existence of several
GABAA-receptor subunits and drug-specific diffe-
rences in GABAA activity (Branson, 2007; Lambert et
al., 2003; Muir et al., 2009). Overall, barbiturates,
propofol, etomidate and alfaxalone decrease neuronal
activity, thus decreasing the demand for oxygen by the
brain. As metabolism is coupled to CBF, a parallel de-
crease in CBF occurs, resulting in a decline of ICP
(Bazin, 1997; Kaisti et al., 2003; Werner, 1995).
Barbiturates
Barbiturates administered at lower concentrations
cause a neuronal depression by decreasing the rate of
dissociation of GABA from the GABA receptor. How-
ever, at higher concentrations they start to activate di-
rectly the chloride ion channel associated with the
GABA receptors (Dunwiddie et al., 1986; Huidobro-
toro et al., 1987; Schwartz et al., 1985). In humans and
dogs, barbiturates were reported to produce a 50% re-
duction in CBF and cerebral metabolism, while cere-
brovascular reactivity to carbon dioxide was mostly
maintained (Akca, 2006; Kassell et al., 1981). Fur-
thermore, thiopental in humans and pentobarbital in
dogs were shown to decrease the CBF, together with a
decrease in cerebral oxygen demand (Chin et al., 1983;
Pierce et al., 1962).
Propofol
Propofol, an injectable anesthetic unrelated to bar-
biturates, induces depression of the central nervous
system by enhancing the effects of the inhibitory neu-
rotransmitter GABA (Concas et al., 1991). 
Different studies in healthy human subjects showed
reductions in CBF, CMRO2 and cerebral blood volume
(CBV) after the administration of propofol (Byas-
Smith et al., 2002; Alkire et al., 1995; Fiset et al., 1999;
Kaisti et al., 2003; Vandesteene et al., 1988). The re-
ported reductions in CMRO2 were greater than the one
observed after the administration of thiopental with less
cerebral vasoconstriction and reduction of CBF (New-
man et al., 1995). These findings were suggestive that
propofol might be more justified in relation to the
cerebral oxygen supply/demand ratio. 
Similar to its effect in man, propofol was reported
to decrease CBF and CMRO2 in dogs with preservation
of the vasoconstrictor reflex to hypocapnia. However,
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the autoregulation was impaired, but only at high
propofol concentrations (Artru et al., 1992). The re-
duction of CBF was dose dependent until electro -
encephalogram (EEG) isoelectricity was obtained and
was also coupled to a reduced cerebral metabolism.
However, when the larger doses required to obtain
isoelectricity were administered, no further reduction
in cerebral metabolism was observed (Artru et al.,
1992). In contrast, exceedingly large doses of propofol
in humans can even increase CBF due to the drug’s in-
trinsic vasodilator effect (Akca, 2006). Propofol also
decreased the ICP in an experimental model of cerebral
edema in cats, (Nimkoff et al., 1997). 
Similar to the study by Artru et al. (1992) in dogs,
cerebral autoregulation and the response to hypercap-
nia were reported to be maintained in humans. Only the
effect of hypocapnia for decreasing CBF may be
blunted in patients receiving propofol infusion for the
maintenance of anesthesia (Conti et al., 2006; Karsli et
al., 2004; Van Aken and Van Hemelrijck, 1991).
Etomidate
The imidazole derivative etomidate appears to work
through GABA receptor activation in a similar way as
propofol (Blednov et al., 2003; Lingamaneni and Hem-
mings, 2003; Vanlersberghe and Camu, 2008). Etomi-
date administered in dogs as a continuous rate infusion
induced decreases in CBF and CMRO2; the decrease of
CMRO2 continued until the onset of an isoelectric
electroencephalogram. The decrease in CBF seemed to
be the result of a potent intrinsic vasoconstrictive effect
of the drug, as it was not coupled to the decrease in
CMRO2 (Milde et al., 1985).
Alfaxalone
Recently, a new formulation of alfaxalone in a cyl-
codextran solution has been developed for use in small
animals (Alfaxan®, Vétoquinol UK Limited, Buck-
ingham, UK). The effects of this formulation on cere-
bral hemodynamics are not known. However, because
alfaxalone also modulates GABAA receptors, and con-
sidering the  properties of the older alfaxalone-al-
fadolone combination in cats and humans, a decrease
in CBF is most likely to occur after the administration
of alfaxalone (Baldy-Moulinier et al., 1975; Bendtsen
et al., 1985; Rasmussen et al., 1978; Sari et al., 1976).
In conclusion, all four injectable anesthetic agents
decrease the oxygen requirements of the brain suffi-
ciently to provide favorable cerebral protection, al-
though propofol decreases CMRO2 to a greater extent
compared to etomidate or thiopental. As autoregulation
is preserved or a specific drug, namely etomidate, has
intrinsic cerebral vasoconstrictive effects, CBF is re-
duced after administration of each of these drugs.
Influence of ketamine
Ketamine is a dissociative anesthetic which in-
terrupts ascending transmission from unconscious to
conscious parts of the brain. There is also evidence of
a dissociation between the thalamus and limbic system
(Lin, 2007). Antagonism at the N-methyl-D-aspartate
(NMDA) receptor has been proposed as the most likely
molecular mechanism responsible for the anesthetic
and analgesic effects of ketamine.
Ketamine does not cause changes in CMRO2 and
CBF in the whole brain. Only regional increases in
CMRO2, CBF and glucose utilization have been re-
ported in rats (Cavazzuti et al., 1987; Chi et al., 1994).
However, the influence of ketamine on cerebral he-
modynamics depends also on the ventilation mode ap-
plied during anesthesia. CBF increases in sponta-
neously breathing human volunteers, but not when
ventilation is controlled (Himmelseher and Durieux,
2005). This increase in CBF during spontaneous ven-
tilation was also reported in cats and might be caused
by sympathetically induced hypertension related to
the occurrence of hypercapnia (Bazin, 1997; Hassoun
et al., 2003; Lin, 2007). Increased CBF can also be a
direct result of hypercapnia because ketamine only
blunts the cerebrovascular reactivity to CO2 in isoflu-
rane anesthetized humans (Nagase et al., 2001). Keta-
mine decreased the cerebrovascular reactivity only to
some extent and did not block the mechanism com-
pletely in spontaneously breathing anaesthetized dogs
(Ohata et al., 2001).
The results of studies under controlled ventilation
are more conflicting. A significant increase in CBF in
ventilated humans after the administration of subanes-
thetic doses of racemic ketamine as well as of the S-
enantiomer of ketamine was reported without changes
in CMRO2 or glucose metabolic rate (Langsjo et al.,
2003; Langsjo et al., 2005). Similar results were re-
ported in ventilated rabbits (Oren et al., 1987). On the
other hand, ketamine caused a decrease in CMRO2
with no change in CBF in ventilated goats (Schwedler
et al., 1982). 
The influence of ketamine on cerebral hemody-
namics depends on the combination with other seda-
tive/anesthetic drugs that is used. When ketamine was
combined with midazolam in human patients with se-
vere head injury that were being mechanically venti-
lated (controlled mode), intracranial and cerebral per-
fusion pressures were maintained to the same extent as
when the combination of midazolam with sufentanil
was used. However, with the increasing trend to use va-
sopressors to control arterial pressure in the sufentanil
group, more fluids were needed (Bourgoin et al., 2003).
Ketamine was even associated with a significant de-
crease in ICP when a propofol infusion was used in
ventilated patients (Albanese et al., 1997). On the other
hand, ketamine may increase CBF in the presence of
nitrous oxide in man, even under controlled ventilation
(Takeshita et al., 1972). Although ketamine reduced the
isoflurane induced cerebral vasodilation during isoflu-
rane anesthesia in rabbits, an increase or no change in
CBF was reported in humans when ketamine was
added to isoflurane anesthesia (Mayberg et al., 1995;
Nagase et al., 2003; Strebel et al., 1995).Moreover, nei-
ther topical nor systemic administration of ketamine in-
duced changes in pial arteriolar diameter in dogs anes-
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thetized with pentobarbital or isoflurane (Ohata et al.,
2001).
Apparently, several factors such as the dosage of ke-
tamine, the ventilation method, the presence of back-
ground anesthesia and species differences contribute to
the differences observed. Consequently, ketamine
causes an increase rather than a decrease in CBF, pro -
bably because ketamine does not induce a generalized
suppression of the brain metabolism. Additionally, the
possibility of regional changes has been mentioned by
several authors. 
Influence of nitrous oxide (N2O)
Although N2O has clear analgesic properties, it is
not an anesthetic agent for sole use in man or animals,
as it is not potent enough to anesthetize a fit, healthy
individual. Since the potency of N2O in animals is
only about half that which has been established in hu-
mans, N2O in veterinary clinical practice is primarily
an anesthetic adjuvant (Steffey and Mama, 2007).
N2O was reported to induce an increased CBF in
people and goats when used alone (30% to 70% inspi -
ratory concentration) (Aono et al., 1999; Field et al.,
1993; Pelligrino et al., 1984). In combination with
sevoflurane (1 MAC) or propofol, nitrous oxide also
increases cerebral blood flow velocity in healthy
children (Rowney et al., 2004; Wilson-Smith et al.,
2003).  Simi larly, inhalation of nitrous oxide caused
increases in CBV, CMRO2 and CBF in dogs (Archer et
al., 1987; Theye and Michenfe, 1968). 
Nitrous oxide either has a direct effect on the
cerebral vessels or it activates certain brain regions,
resulting in an increased CMRO2 (Hancock et al.,
2005; Matta and Lam, 1995; Theye and Michenfe,
1968). Interestingly, studies in both humans and goats
showed regional differences of the effect of nitrous
oxide on the CBF (Lorenz et al., 2001; Pelligrino et
al., 1984).  In humans, no effect on the dynamic
cerebrovascular response to arterial CO2 changes were
observed; cerebral autoregulation, however, was im -
pai red when N2O was administered without addi tional
anesthetics (Audibert et al., 2005; Girling et al., 1999).
Unfortunately, studies of these specific issues are not
available in small animals.
Influence of volatile anesthetics
Volatile anesthetics generally increase CBF in a
dose-dependent manner, while progressively depress-
ing cerebral metabolism, thereby challenging the clas-
sic “neuronal activity ≈ metabolism ≈ blood flow”
paradigm (Kaisti et al., 2003; Mielck et al., 1999). The
disproportion between brain perfusion and metabo-
lism becomes obvious when the CBF/CMRO2 ratio is
calculated. All volatile anesthetics cause an increase of
this ratio both in humans and in dogs. The increase is
more pronounced when isoflurane is used, compared to
halothane and sevoflurane. These differences are most
likely induced by the weaker vasodilating effect of
sevoflurane, whereas some have suggested that the
metabolism is decreased less when halothane is used
(Algotsson et al., 1988; Hansen et al., 1989; Kuroda et
al., 1996; Oshima et al., 2003; Scheller et al., 1990).
Since not all volatile anesthetics suppress the brain me-
tabolism to the same extent, this difference has been ac-
cepted as another confounding factor resulting in the
recorded CBF alterations.
Volatile anesthetics have both a direct intrinsic
dilating effect on cerebral vessels and an indirect ex -
trinsic constricting effect related to the depression of
the brain metabolism (Hans and Bonhomme, 2006;
Ogawa et al., 1997). Consequently, the decrease in
cerebral blood flow due to the decreased cerebral
metabolism is less than expected because of this direct
vasodilating effect. The intrinsic vasodilating effect is
dose dependent and more pronounced for halothane
and desflurane compared to isoflurane and sevoflurane
(De Deyne et al., 2004; Hansen et al., 1989;  Kuroda
et al., 1996; Matta and Lam, 1995; Matta et al., 1999;
Ogawa et al., 1997). The weaker intrinsic vasodilatory
action of sevoflurane also explains the well maintained
cerebral autoregulation and cerebrovascular CO2
reactivity, as well as the constant intracranial pressure,
in both Sevoflurane anesthetized humans and dogs
(Artru et al., 1997; Cho et al., 1996; Gupta et al., 1997;
Takahashi et al., 1993). These characteristics make
sevoflurane the volatile anesthetic of choice for brain
compromised patients.
In an awake patient or during a light plane of anes-
thesia where CMR is high, the reduction in CMR
caused by the volatile anesthetic produces a decrease
in CBF (Summors et al., 1999). However, if the CMR
is already low, CBF increases by direct vasodilation.
Therefore, flow-metabolism coupling is preserved at
low concentrations of isoflurane and sevoflurane, and
the net effect is a reduction in CBF. When high con-
centrations of both volatiles are used, CBF increases
with a loss of cerebral autoregulation. This conclusion
is supported by the observation of a reduction of CBF
during the administration of sevo- and desflurane,
compared to the awake state, both in man and in dogs
(Mielck et al., 1998; Mielck et al., 1999). Halothane
seems to be an exception as, at least in cats, CBF is as-
sumed to increase compared to the awake state when
using this volatile anesthetic (Hassoun et al., 2003).
In humans, volatile anesthetics produce not only
global but also regional CBF alterations due to diffe -
rent effects on the anterior and posterior circulation.
The location and the magnitude of these flow alter-
ations depend on the kind of anesthetic and its con-
centration (Kaisti et al., 2003; Reinstrup et al., 1995;
Schlunzen et al., 2006; Schlunzen et al., 2004). 
Besides the ability to change the tone of the cerebral
resistance vessels, volatile anesthetics can also influ-
ence autoregulation, again in an anesthetic- and dose-
dependent manner (De Deyne et al., 2004; Miletich et
al., 1976; Morita et al., 1977). When high doses of
volatile anesthetics are administered, the cerebral ves-
sels are already maximally dilated and therefore can-
not further compensate when the systemic blood pres-
sure decreases. In humans, it is generally accepted that
cerebrovascular autoregulation is maintained up to 1.5
MAC, but becomes progressively impaired at higher
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concentrations (Akca, 2006; De Deyne et al., 2004;
Gupta et al., 1997; Summors et al., 1999).
The response to CO2, as such, is more or less main-
tained during the administration of volatile anesthetics.
There are two mechanisms altering the tone of the
cerebral vessels, and mutual interference occurs be-
tween them. In rats, for example, hypercapnia increases
CBF less during isoflurane anesthesia than in the
awake animal (Sicard et al., 2003). Also in dogs and
cats, the vasoconstriction of the cerebral vasculature,
induced by hypocapnia, is maintained during different
levels of isoflurane anesthesia, whereas the vasodila-
tion response to hypercarbia is impaired, but only at
higher isoflurane concentrations (Drummond and
Todd, 1985; McPherson et al., 1989). Halothane, how-
ever, attenuated the hypocapnia-induced vasoconstric-
tion to a larger extent than isoflurane or sevoflurane in
an in vitro study on isolated dog cerebral arteries
(Ogawa et al., 1997).
The data in the literature on the effects on the CBF
of all volatile anesthetics in general, and of isoflurane
in particular, are not consistent. Because of counter-
acting mechanisms, dose dependency, concurrent ad-
ministration of other anesthetics, the influence of no-
ciception in surgical studies, different measurement
methods and possible species differences, the results
obtained are often difficult to compare. A distinction
has to be made when comparing volatile anesthetics to
one another or when comparing the awake state to
anesthetic conditions. Another important factor is the
duration of administration of the volatile agent, as
CBF has been reported to decrease over time in isoflu-
rane anesthetized dogs (Brian et al., 1990; McPherson
et al., 1991). An overview of the effects of volatile
anesthetics on brain perfusion and metabolism is pro-
vided in Table 1.
CONCLUSION
A review of the literature on the effects of anesthe-
sia on the cerebral hemodynamics reveals that every
single sedative or anesthetic drug has a clear effect.
These products affect cerebral perfusion not only by
changing the tone of the cerebral vessels themselves,
but also by changing the cerebral metabolism. These
effects have important consequences for the regulation
of CBF during brain surgery. Moreover, when evalua -
ting brain perfusion with imaging modalities, the use
of different anesthetic protocols may result in unreli-
able results. Especially in situations where regional
cerebral blood flows are compared, anesthetic induced
regional blood flow changes should be avoided and
anesthetics causing only global changes should be pre-
ferred. The use of anesthetics results in regional blood
flow changes possibly causing significant alterations of
distribution of the ligand in specialized neuroreceptor
ligand studies. To be able to compare different brain re-
gions at a specific moment or to compare specific
measurements in the same animal at different time
points, it is justified to avoid anesthetics causing rCBF
changes. Moreover, the use of a standardized dosage is
extremely important for these procedures.
Because changes in CBF can also occur as a result
of changes in arterial oxygen and carbon dioxide ten-
sions and of blood pressure, all of which are influenced
by the level of anesthesia, the results are not easy to
predict. Therefore these secondary changes should be
minimized by keeping the blood pressure and the ar-
terial oxygen and carbon dioxide tensions within phy -
siological ranges, thereby reducing the influence of the
anesthesia on the cerebral hemodynamics. 
Table 1. Effects of volatile anesthetics on brain perfusion and metabolism.
Anesthetic Species CBF CMRO2 Vmca Compared to Reference
Halothane Cat ↑ Awake Hassoun et al. 2003
Halothane Cat ↑ ↓   N2O+O2 Todd and Drummond, 1984
Halothane Man ↑ Isoflurane Young et al. 1989
Halothane Baboon ↓→↑ ↓   Phencyclidine+N2O Brüssel et al. 1991
Halothane Man ↑ ↑   Fentanyl+N2O Algotsson et al, 1988
Sevoflurane Man ↓ Sufentanil+N2O Artru et al. 1997
Sevoflurane Man ↑ ↓   Midazolam+fentanyl Oshima et al. 2003
Sevoflurane Man ↓ Awake Cho et al. 1996
Sevoflurane Man ↓ Awake Conti et al. 2006
Sevoflurane Man ↓ Awake Gupta et al. 1997
Sevoflurane Man ↓ ↓   Awake Mielck et al. 1999
Desflurane Dog ↑    Desflurane (lower concentration) Lutz et al. 1990
Desflurane Man ↓ ↓   Awake Mielck et al. 1998
Desflurane Pig ↑     Isoflurane Holmström and Akeson, 2003
Desflurane Dog ↓     Desflurane (lower concentration) Milde and Milde 1991
Isoflurane Cat ↔ ↓   N2O+O2 Todd and Drummond, 1984
Isoflurane Man ↑ ↓   Midazolam+fentanyl Oshima et al. 2003
Isoflurane Man ↔ ↓  Fentanyl+N2O Algotsson et al, 1988
Isoflurane Man ↓ Sufentanil+N2O Artru et al. 1997
Isoflurane Dog ↓ ↓  Isoflurane (lower concentration) Zornow et al. 1990
CMRO2: cerebral metabolic rate of oxygen consumption
CBF: cerebral blood flow
Vmca: middle cerebral artery flow velocity
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